These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16949225)

  • 21. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin.
    Príborský J; Takayama K; Nagai T; Waitzová D; Elis J
    Drug Des Deliv; 1987 Dec; 2(2):91-7. PubMed ID: 3334547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.
    Nada AH; Zaghloul AA; Hedaya MM; Khattab IS
    Acta Pharm; 2014 Sep; 64(3):299-309. PubMed ID: 25296676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride.
    Han IH; Choi SU; Nam DY; Park YM; Kang MJ; Kang KH; Kim YM; Bae G; Oh IY; Park JH; Ye JS; Choi YB; Kim DK; Lee J; Choi YW
    Arch Pharm Res; 2010 Feb; 33(2):293-9. PubMed ID: 20195831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
    Wen Z; Fang L; He Z
    Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of penetration enhancer on drug permeation from volatile formulations.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2012 Dec; 439(1-2):260-8. PubMed ID: 23000063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
    Tirunagari M; Jangala VR; Khagga M; Gannu R
    Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal microemulsions of Boswellia carterii Bird: formulation, characterization and in vivo evaluation of anti-inflammatory activity.
    Mostafa DM; Ammar NM; Basha M; Hussein RA; El Awdan S; Awad G
    Drug Deliv; 2015; 22(6):748-56. PubMed ID: 24725029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and in-vivo evaluation of ondansetron gels for transdermal delivery.
    Patel DR; Joshi A; Patel HH; Stagni G
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1030-6. PubMed ID: 24919508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique structure and property of cyclodextrins and their application in transdermal drug delivery.
    Hu J; Tao Z; Cao S
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):449-56. PubMed ID: 19907720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety.
    El-Setouhy DA; El-Ashmony SM
    J Pharm Pharmacol; 2010 Jan; 62(1):25-34. PubMed ID: 20722996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration.
    Chen H; Mou D; Du D; Chang X; Zhu D; Liu J; Xu H; Yang X
    Int J Pharm; 2007 Aug; 341(1-2):78-84. PubMed ID: 17570625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system.
    Hirakawa Y; Ueda H; Miyano T; Kamiya N; Goto M
    Int J Pharm; 2019 Oct; 569():118582. PubMed ID: 31381987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
    Choi A; Gang H; Chun I; Gwak H
    Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of the loratadine gel for enhanced transdermal delivery.
    Song JH; Shin SC
    Drug Dev Ind Pharm; 2009 Aug; 35(8):897-903. PubMed ID: 19241201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocarrier-based topical drug delivery for an antifungal drug.
    Hussain A; Samad A; Nazish I; Ahmed FJ
    Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE).
    Suppasansatorn P; Nimmannit U; Conway BR; Du L; Wang Y
    J Pharm Pharmacol; 2007 Jun; 59(6):787-94. PubMed ID: 17637171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.